The Board and Pasona want the highest possible price. M3's inability to table a revised offer suggests that Dai-ichi Life has set the bar too high. There is a low probability of a M3 revised bid.
Boomeranged on Tue, 30 Jan 2024 15:16
Dai-ichi Life updates on the progress of the Benefit One tender. Discussions continue with the aim of commencing the offer in mid-February (aligns with the close of the M3 partial offer). The development suggests the Board and Pasona seek to start a bidding war without pushing away Dai-ichi Life. At the last close, Benefit One shares are trading marginally above Dai-ichi Life’s offer.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.